Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls

Shah, Urvi A.; Rögnvaldsson, Sæmundur; Derkach, Andriy; Björkholm, Magnus; Turesson, Ingemar; David, Yael; Hultcrantz, Malin; Tan, Carlyn; Hassoun, Hani; Korde, Neha; Lesokhin, Alexander; Mailankody, Sham; Kristinsson, Sigurður Yngvi; Ola Landgren, C.

Opin vísindi
→
IRIS
→
IRIS
→
View Item

dc.contributor.author	Shah, Urvi A.
dc.contributor.author	Rögnvaldsson, Sæmundur
dc.contributor.author	Derkach, Andriy
dc.contributor.author	Björkholm, Magnus
dc.contributor.author	Turesson, Ingemar
dc.contributor.author	David, Yael
dc.contributor.author	Hultcrantz, Malin
dc.contributor.author	Tan, Carlyn
dc.contributor.author	Hassoun, Hani
dc.contributor.author	Korde, Neha
dc.contributor.author	Lesokhin, Alexander
dc.contributor.author	Mailankody, Sham
dc.contributor.author	Kristinsson, Sigurður Yngvi
dc.contributor.author	Ola Landgren, C.
dc.date.accessioned	2022-08-24T01:02:39Z
dc.date.available	2022-08-24T01:02:39Z
dc.date.issued	2022-01-01
dc.identifier.citation	Shah , U A , Rögnvaldsson , S , Derkach , A , Björkholm , M , Turesson , I , David , Y , Hultcrantz , M , Tan , C , Hassoun , H , Korde , N , Lesokhin , A , Mailankody , S , Kristinsson , S Y & Ola Landgren , C 2022 , ' Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls ' , Haematologica , vol. 107 , no. 1 , pp. 284-286 . https://doi.org/10.3324/haematol.2021.278772
dc.identifier.issn	0390-6078
dc.identifier.other	45095406
dc.identifier.other	8640bc56-3213-4391-b674-6948a6651b38
dc.identifier.other	85122319750
dc.identifier.other	34474548
dc.identifier.other	unpaywall: 10.3324/haematol.2021.278772
dc.identifier.other	000740550800029
dc.identifier.uri	https://hdl.handle.net/20.500.11815/3333
dc.description	Funding Information: This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748 (UAS) and supported by grants from Swedish Cancer Society (MB), Parker Institute of Cancer Immunotherapy Career Development Award (YD, UAS), International Myeloma Society Career Development Award, Paula and Rodger Riney Foundation, American Society of Hematology Clinical Research Training Institute Award and TREC Training Workshop R25CA203650 (PI: Melinda Irwin) (UAS). Funding Information: Contributions: all authors participated in the writing and review of the manuscript. Additionally UAS and SR designed the study and performed data analysis; AD performed data analysis and designed statistical methods; MB and IT curated the data and were involved in study design conception; YD, SP, MH, CT, HH, NK, AL, and SM were involved in study design conception; SYK and COL curated the data, designed the study, and supervised the research project. Acknowledgments: the authors would like to thank Hannah Rice, BA, ELS for editorial assistance. Funding: this research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748 (UAS) and supported by grants from Swedish Cancer Society (MB), Parker Institute of Cancer Immunotherapy Career Development Award (YD, UAS), International Myeloma Society Career Development Award, Paula and Rodger Riney Foundation, American Society of Hematology Clinical Research Training Institute Award and TREC Training Workshop R25CA203650 (PI: Melinda Irwin) (UAS). Data sharing statement: The data included in study is built on multiple population-based registries including the medical records of Swedish citizens. Although the data has been made unidentifiable before analysis, ethical board approval does not permit data sharing.
dc.format.extent	3
dc.format.extent	232406
dc.format.extent	284-286
dc.language.iso	en
dc.relation.ispartofseries	Haematologica; 107(1)
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	Diabetes Mellitus
dc.subject	Humans
dc.subject	Lymphoproliferative Disorders/diagnosis
dc.subject	Plasma Cells
dc.subject	Sykursýki
dc.title	Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls
dc.type	/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/letter
dc.description.version	Peer reviewed
dc.identifier.doi	10.3324/haematol.2021.278772
dc.relation.url	http://www.scopus.com/inward/record.url?scp=85122319750&partnerID=8YFLogxK
dc.contributor.department	Internal Medicine and Emergency Services
dc.contributor.department	Faculty of Medicine
dc.contributor.department	Cancer Center